Introduction {#sec1-1}
============

Skeletal muscle atrophy is associated with morphological changes, including loss of muscle mass[@ref1] and reduced cross-sectional area (CSA) of the muscle fibers[@ref2]. Muscle atrophy can be caused by inflammatory diseases, such as sepsis, cancer, and chronic obstructive pulmonary disease, as well as muscle disuse[@ref3],[@ref4]. Sepsis is a complex series of linked inflammatory and hemostatic changes that may occur in response to infection[@ref5]. In addition, sepsis-induced muscle atrophy is associated with a preferential atrophy of fast muscle fibers, while the disuse condition induces a preferential atrophy of slow muscle fibers[@ref6]. Muscle atrophy is mediated by decreased protein synthesis and increased protein degradation[@ref1]. Inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), are increased under sepsis conditions[@ref7]. Additionally, inflammatory cytokines can increase muscle protein degradation[@ref2]. Furthermore, skeletal muscle protein degradation under severe inflammatory conditions, such as sepsis, occurs primarily through the activation of the ubiquitin-proteasome pathway[@ref2]. Therefore, blocking the activated ubiquitin-proteasome pathway may prevent sepsis-induced muscle atrophy.

Generally, resistance exercise training is an effective therapeutic intervention to prevent the muscle atrophy induced by diverse conditions[@ref8]. However, it is difficult for severely ill patients to perform resistance exercises. In addition, sepsis can induce severe conditions in patients, making it difficult to perform the therapeutic resistance exercises. Electrical stimulation is an effective countermeasure and substitute for resistance exercise training, and can prevent muscle atrophy in severely ill patients[@ref9]-[@ref12]. In our previous study, the increased expression of ubiquitinated proteins, which is an indicator of ubiquitin-proteasome pathway activation in atrophied muscles, was inhibited by the muscle contractions elicited by low frequency, pulsed current electrical stimulation[@ref13],[@ref14]. Therefore, electrical stimulation can be an effective therapeutic intervention for sepsis-induced muscle atrophy and disuse atrophy. However, pulsed current stimulation, which commonly used in the clinic, cannot elicit muscle contractions in the vast majority of muscles due to its low conductivity[@ref15]. Low conductivity can be induced in adipose tissue, which has capacitance[@ref15]. In addition, the electrical resistance of a capacitor is equal to 1/2πFC, where F is frequency and C is capacitance. Therefore, a higher frequency results in lower electrical resistance (impedance) to muscle stimulation. Electrical stimulation using a kilohertz frequency alternating current can also stimulate skeletal muscles[@ref16], because it has a higher frequency than the commonly used pulsed current[@ref16]. In addition, electrical stimulation using kilohertz frequency alternating current is more comfortable for the patient than the pulsed current, and can elicit contraction in a vast range of muscle fibers[@ref12],[@ref16]. Thus, electrical stimulation using kilohertz frequency alternating current, which is a type of burst-modulated alternating current, may be a more efficient therapeutic intervention for muscle atrophy than pulsed current electrical stimulation.

It is not clear if electrical stimulation is effective in preventing sepsis-induced muscle atrophy or in attenuating the ubiquitin-proteasome pathway activation via sepsis-induced inflammatory cytokines. We hypothesized that the electrical stimulation may be more effective in preventing sepsis-induced muscle atrophy via the attenuation of the ubiquitin-proteasome pathway activation. If verified, this could establish a new therapeutic modality that targets sepsis-induced muscle atrophy. The purpose of the present study was to evaluate the effects of electrical stimulation using kilohertz frequency (ES) on sepsis-induced muscle atrophy. To understand the role of the ubiquitin-proteasome pathway involved in this effect, we also analyzed the changes of myostatin, Akt/FoxO signaling, atrogin-1, and ubiquitinated proteins as major regulators or indicators of the pathway.

Methods {#sec1-2}
=======
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### Experimental groups {#sec3-1}

A pilot study using 5 adult male ICR mice (body weight 30±1 g \[mean ± SEM\]; 6 weeks old; Japan SLC, Hamamatsu, Japan) provided information on the duration required to induce sepsis, after 1 week familiarization period. For the electrical stimulation study, 17 adult male ICR mice (body weight 30±1 g; 6 weeks old; Japan SLC, Hamamatsu, Japan) were randomly divided into 3 groups: control (Cont; body weight 30±1 g \[mean ± SEM\], n=6), lipopolysaccharide (LPS; body weight 31±1 g, n=5), and LPS plus electrical stimulation (ES) (LPS+ES; body weight 30±1 g, n=6) groups, after 1 week familiarization period. The ES group was subjected to therapeutic ES twice a day for 4 days. This study was approved by the Institutional Animal Care and Use Committee and was performed according to the Kobe University Animal Experimentation Regulations. All experiments were conducted in accordance with the National Institutes of Health (NIH) Guidelines for the Care and Use of Laboratory Animals (National Research Council, 1996).

### Sepsis induce {#sec3-2}

Sepsis was induced by intraperitoneal (i.p.) LPS (10 µg/g body weight/day) injections, which has been previously described[@ref17]. LPS was administered once a day for 7 days; the change in the body weight was measured ([Figure 1](#F1){ref-type="fig"}). The animals had access to food and water *ad libitum*, and were housed in an isolated and environmental controlled room (22±2°C; 12 h-12 h light-dark cycle). The body weight of LPS-treated animals were decreased incriminatory and peaked at day 4 (-21.5%). However, their body weight recovered after days 4 till days 7, suggesting that LPS-induced sepsis advanced in its severity after 4 days and was an adequate period to investigate the preventive effects of an intervention for muscle atrophy. Therefore, we decided the sepsis induction and intervention would occur for 4 days.

![Changes in the body weight of lipopolysaccharide (LPS)-injected animals (daily administration for 7 days). Values are presented as the mean ± SEM.](JMNI-16-152-g001){#F1}

### Electrical stimulation protocol {#sec3-3}

The electrical stimulation began on day 1 of LPS administration and continued for 4 days. The animals in the LPS and LPS+ES groups were anesthetized during the electrical stimulation by an i.p. injection of pentobarbital sodium (40 mg/kg). The animals in the Cont and LPS groups were anesthetized at the same frequency as the LPS+ES group to exclude any influences from the anesthetic. An electrical stimulator (ES-360, Ito, Tokyo, Japan) that permitted electrical parameter changes was used to treat the tibialis anterior muscles transcutaneously. Two surface electrodes (3 mm in diameter) were adhered to the midpoint of both electrodes on the motor point of the tibialis anterior muscle. The stimulation for the LPS+ES group was a burst modulated waveform. The current was delivered at a frequency of 100 Hz. These stimulations could forcefully contract the tibialis anterior muscle, and the current intensity was set daily to produce a supramaximal contraction (25-35 mA). One burst of the electrical stimulation was delivered every 3 s (time on: 1 s; time off: 2 s) for 1 min, followed by 5 min of rest, as previously described[@ref13]. Six consecutive stimulation sessions were performed twice a day, separated by a 9-h interval. The total duration of the electrical stimulation sessions was 240 s per day.

### Sample preparation and histological analysis {#sec3-4}

Twelve hours after the final electrical stimulation, all animals were deeply anesthetized by an i.p. injection of sodium pentobarbital (40 mg/kg), and the tibialis anterior muscle was removed and weighed. The animals were then euthanized by an overdose of sodium pentobarbital. The tibialis anterior muscle samples were immediately frozen in an acetone/dry ice bath and stored at -80°C until histological and western blot analyses. Transverse tissue sections (12 µm thickness) were cut from the middle part of the muscle belly on a cryostat (CM-1510S, Leica Microsystems, Mannheim, Germany) at -25°C, and then mounted on glass slides. The sections were stained for hematoxylin-eosin (HE), as previously described[@ref18]. The stained sections were used to determine the CSAs of the muscle fibers. A total of 1,200 fibers per Cont or LPS+ES group and 1,000 fibers per LPS group (200 fibers per muscle sample) were analyzed from a deep (near the bone) and superficial regions of each muscle. The sections were measured using the Image J software program (NIH, Bethesda, MD, USA).

### Plasma collection and analyses {#sec3-5}

For the plasma collection, the animals were deeply anesthetized by an i.p. injection of pentobarbital sodium (40 mg/kg). The animals then were placed on a heated surgical table, and the abdominal cavity was opened. Blood was drawn from the vena cava and placed on ice. The blood samples then were centrifuged (15,000 × g for 10 min at 4°C), and the plasma supernatant samples were stored at -80°C until the TNF-α protein levels were measured.

### ELISA for TNF-α {#sec3-6}

The plasma TNF-α protein expression levels were determined using a commercially available enzyme-linked immunosorbent assay (ELISA) kit, according to manufacturer's instructions (eBioscience, San Diego, CA, USA).

### Western blot analysis {#sec3-7}

A portion of the frozen tissue samples (20 mg) was homogenized in 5 M urea, 2 M thiourea, 10 mM sodium diphosphate decahydrate, 0.1% (v/v) 2-mercaptoethanol, and 1% (v/v) protease inhibitor cocktail for mammalian tissue (Sigma-Aldrich, Saint Louis, MO, USA); the levels of atrogin-1 and ubiquitinated protein were then determined. Another portion of the samples (20 mg) was homogenized in 1% NP-40, 20 mM Tris-HCl (pH 7.4), 25 mM NaCl, 5 mM EDTA, 5 mM EGTA, 1 mM dithiothreitol, 25 mM β-glycerophosphate, 50 mM NaF, 1% (v/v) protease inhibitor cocktail for mammalian tissue (Sigma-Aldrich), and 1% (v/v) phosphatase inhibitor cocktail for mammalian tissue (Sigma-Aldrich); these samples were used to determine TNF-α, Akt1 and FoxO3a levels. The homogenates were centrifuged at 15,000 × g for 25 min at 4°C. The total protein concentrations were determined with a protein determination kit (Bio-Rad, Hercules, CA, USA). The homogenates were solubilized in a sample loading buffer containing 50 mM Tris-HCl (pH 6.8), 2% sodium dodecyl sulfate, 10% glycerol, 5% β-mercaptoethanol, and 0.005% bromophenol blue. The protein samples (45 µg/lane) were separated by a 10% (for ubiquitinated protein detection) or 12.5% (for atrogin-1, Akt1, FoxO3a, myostatin, and TNF-α detection) SDS-polyacrylamide gel electrophoresis (SDS-PAGE); they were then transferred to polyvinylidene fluoride (PVDF) membranes. The membranes were blocked for 1 h with Tris-buffered saline with Tween 20 (TBST) containing 3% bovine serum albumin (BSA) and then incubated overnight at 4°C with the following primary antibodies: anti-polyubiquitin-protein conjugates (diluted 1:100; Enzo Life Sciences, Farmingdale, NY, USA), anti-atrogin-1 (diluted 1:1000; ECM Biosciences, Versailles, KY, USA), anti-phosphorylated Ser^473^-Akt1 (diluted 1:1000; Cell Signaling, Beverly, MA, USA), anti-Akt1 (diluted 1:1000; Cell Signaling), anti-phosphorylated Ser^253^-FoxO3a (diluted 1:1000; Cell Signaling), anti-FoxO3a (diluted 1:1000; Cell Signaling), anti-myostatin (diluted 1:200; Abcam, Cambridge, UK), and TNF-α (diluted 1:1000; Cell Signaling). The membranes then were incubated for 60 min at room temperature with either anti-mouse or anti-rabbit IgG conjugated to horseradish peroxidase (GE Healthcare, Waukesha, WI, USA). The membranes were developed using a chemiluminescent reagent (ECL, GE Healthcare) and analyzed using an image reader (LAS-1000, Fujifilm, Tokyo, Japan). The digitized signals were quantified using the Multi-Gauge Image Analysis Software program (Fujifilm). β-actin was used as an internal control.

### Statistical analysis {#sec3-8}

The data are expressed as the mean ± SEM. The TNF-α plasma expression levels between the LPS and LPS+ES groups were analyzed by a Student's t-test. Prior to the parametric analysis of variance (ANOVA) analyses, the group variances were tested and found to be not significantly different using the Shapiro-Wilk normality test. A one-way ANOVA was used to analyses the body weight, the muscle wet weight, the muscle fiber CSAs, and western blot protein expression levels among the 3 experimental groups, followed by a Tukey's post hoc test. The statistical significance was set at p\<0.05.

Results {#sec1-3}
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### Muscle wet weight {#sec3-9}

The group mean body weights, muscle wet weights, and muscle to body weight ratios are shown in [Table 1](#T1){ref-type="table"}. After 4 days of LPS administration, the body weights of the LPS and LPS+ES groups were significantly lower than that of the Cont group (LPS: -29.0%, LPS+ES: -23.1%). The tibialis anterior muscle wet weights were significantly lower in the LPS and LPS+ES groups than that of the Cont group. For the tibialis anterior muscle, the muscle wet weights and the ratios of muscle wet weight to body weight in the LPS+ES group were significantly larger than those in the LPS group.

###### 

Body weights, muscle wet weights, and muscle to body weight ratios following electrical stimulation.

                                       Cont        LPS                                         LPS+ES
  ------------------------------------ ----------- ------------------------------------------- -----------------------------------------------------------------------
  Body weight (g)                      33±1        24±1[\*](#t1f1){ref-type="table-fn"}        26±1[\*](#t1f1){ref-type="table-fn"}
  Muscle wet weight (mg)               51±1        34±1[\*](#t1f1){ref-type="table-fn"}        44±1[\*](#t1f1){ref-type="table-fn"}^[†](#t1f2){ref-type="table-fn"}^
  Muscle to body weight ratio (mg/g)   1.51±0.02   1.42±0.05[\*](#t1f1){ref-type="table-fn"}   1.71±0.07^[†](#t1f2){ref-type="table-fn"}^

Values are the mean ± SEM. Control (Cont) and lipopolysaccharide (LPS) plus electrical stimulation (ES) groups, n=6; LPS group, n=5. Cont, no treatment; LPS, LPS injection for 4 days; LPS+ES, LPS plus electrical stimulation.

and

indicate significant differences from the control and LPS groups, respectively, at P\<0.05.

### Muscle fiber CSA {#sec3-10}

In the whole (superficial + deep) ([Figure 2a](#F2){ref-type="fig"}), superficial ([Figure 2b](#F2){ref-type="fig"}), and deep layer ([Figure 2c](#F2){ref-type="fig"}) of tibialis anterior muscle, the CSAs of the muscle fibers were significantly smaller in the LPS and LPS+ES groups than in the Cont group. However, the CSAs in the LPS+ES group were significantly larger than those in the LPS group.

![Transverse sections of the tibialis anterior muscle stained for hematoxylin (HE). Control (Cont) group (a); Lipopolysaccharide (LPS) group (b); LPS+ electrical stimulation (ES) group (c). Bar = 100 µm. Cross-sectional areas of whole (superficial + deep) muscle fibers ([Figure 2a](#F2){ref-type="fig"}), superficial ([Figure 2b](#F2){ref-type="fig"}), and deep layer ([Figure 2c](#F2){ref-type="fig"}) in the tibialis anterior muscle. Values are presented as the mean ± SEM. \* and † indicate significant differences from the Cont and LPS groups, respectively, at P\<0.05.](JMNI-16-152-g002){#F2}

### TNF-α expression {#sec3-11}

The TNF-α plasma expression levels were not detected in the Cont group, because the values were too small and resided outside the calibration curve ([Figure 3A](#F3){ref-type="fig"}). The TNF-α plasma expression levels in the LPS and LPS+ES groups were increased compared to that of the Cont group, although these differences were not statistically significant.

![TNF-α protein concentration levels in plasma ([Figure 3A](#F3){ref-type="fig"}) and expression levels of in the tibialis anterior muscle ([Figure 3B](#F3){ref-type="fig"}). Values are mean ± SEM. nd: not detected. Representative western blots indicate the expression of TNF-α in the tibialis anterior muscle. The histogram shows the quantification of the band densities. The expression levels were calculated as the fold change relative to the control (Cont) group. \* indicates significant differences from the Cont and lipopolysaccharide (LPS), respectively, at P\<0.05.](JMNI-16-152-g003){#F3}

The TNF-α expression in the tibialis anterior muscle was significantly higher in the LPS group than that in the Cont group ([Figure 3B](#F3){ref-type="fig"}). However, there were no significant differences between the Cont and LPS+ES groups.

### Myostatin expression {#sec3-12}

Myostatin expression in the tibialis anterior muscle was significantly higher in the LPS and LPS+ES groups than that in the Cont group ([Figure 4](#F4){ref-type="fig"}). However, myostatin expression in the LPS+ES group was significantly lower than that of the LPS group.

![Expression levels of myostatin in the tibialis anterior muscle. Representative western blots indicate the expression of myostatin. The histogram shows the quantification of the band densities. The expression levels were calculated as the fold change relative to the control (Cont) group and are presented as the mean ± SEM. \* and † indicate significant differences from the Cont and lipopolysaccharide (LPS), respectively, at P\<0.05.](JMNI-16-152-g004){#F4}

### Akt/FoxO pathway {#sec3-13}

The ratios of phosphorylated Akt1 to total Akt1 protein ([Figure 5](#F5){ref-type="fig"}) and of phosphorylated FoxO3a to total FoxO3a protein ([Figure 6](#F6){ref-type="fig"}) were lower in the LPS group compared to that of the Cont group. However, the LPS+ES group levels were significantly larger than those in the LPS group.

![The ratios of phosphorylated Akt1 to total Akt1 protein in the tibialis anterior muscle. Representative western blots indicate the levels of phosphorylated Akt1 and total Akt1 protein. The histogram shows the ratio of phosphorylated and total Akt1 protein band densities. The ratios of phosphorylated and total protein levels were calculated as the fold change relative to the control (Cont) group and are presented as mean ± SEM. \* and † indicate significantly different from the Cont and lipopolysaccharide (LPS), respectively, at P\<0.05.](JMNI-16-152-g005){#F5}

![The ratio of phosphorylated FoxO3a to total FoxO3a protein in the tibialis anterior muscle. Representative western blots indicate the expression of phosphorylated FoxO3a and total FoxO3a protein. The histogram shows the ratio of phosphorylated and total FoxO3a protein band densities. The ratio of phosphorylated and total protein levels was calculated as the fold change relative to the control (Cont) group and are presented as the mean ± SEM. \* and † indicate significant differences from the Cont and lipopolysaccharide (LPS), respectively, at P\<0.05.](JMNI-16-152-g006){#F6}

### Ubiquitin-proteasome pathway {#sec3-14}

Atrogin-1 expression in the tibialis anterior muscle was significantly higher in the LPS and LPS+ES groups than that in the Cont group ([Figure 7](#F7){ref-type="fig"}). However, atrogin-1 expression in the LPS+ES group was significantly lower than that of the LPS group. The expression levels of the ubiquitinated proteins in the tibialis anterior muscle were significantly higher in the LPS and LPS+ES groups than the levels in the Cont group ([Figure 8](#F8){ref-type="fig"}). The expression levels in the LPS+ES group were significantly lower than the levels in the LPS group.

![Expression levels of atrogin-1 in the tibialis anterior muscle. Representative western blots indicate the expression of atrogin-1. The histogram shows the quantification of the band densities. The expression levels were calculated as the fold change relative to the control (Cont) group and are presented as the mean ± SEM. \* and † indicate significant differences from the Cont and lipopolysaccharide (LPS), respectively, at P\<0.05.](JMNI-16-152-g007){#F7}

![Expression of ubiquitinated proteins in the tibialis anterior muscle. Representative western blots and histograms showing the quantification of the band densities. Values were calculated as the fold change relative to the control (Cont) group and are presented as the mean ± SEM. \* and † indicate significant differences from the Cont and lipopolysaccharide (LPS), respectively, at P\<0.05.](JMNI-16-152-g008){#F8}

Discussion {#sec1-4}
==========

In the present study, we found that kilohertz frequency electrical stimulation inhibited the sepsis-induced loss of muscle mass, improved the reduction of muscle fiber CSA, and lowered the increased expression of atrogin-1 and ubiquitinated proteins in the tibialis anterior muscle, which contributed to the prevention of muscle atrophy under septic conditions ([Figure 9](#F9){ref-type="fig"}).

![Schematic representation of the role of the Akt signaling pathway and ubiquitin-proteasome pathway in sepsis-induced muscle atrophy (A) and in the amelioration of atrophy by electrical stimulation (B). Boldface arrows, activation; boldface blunt bars, inhibition; upward arrows, up-regulation; downward arrows, down-regulation.](JMNI-16-152-g009){#F9}

Four days of LPS-induced sepsis caused loss of muscle mass and fiber CSA, increased inflammatory cytokines and increased the expression of atrogin-1 and ubiquitinated proteins in the tibialis anterior muscle. Previous studies have suggested that sepsis involves inflammation caused by a reduction in muscle protein synthesis and an increase in muscle protein degradation[@ref3],[@ref19],[@ref20]. In addition, the sepsis-induced protein degradation is primarily caused by the ubiquitin-proteasome pathway[@ref20],[@ref21]. In the ubiquitin-proteasome pathway, there are 2 degradation steps for muscle protein. The first step is the formation of ubiquitinated proteins, which are ubiquitin molecules conjugated to the target proteins as the tag for degradation. The second step is the degradation of the tagged protein by the 26S proteasome[@ref22]. In the first step, muscle-specific ubiquitin ligases, such as atrogin-1, play an important role for increasing ubiquitinated proteins[@ref22]. In addition, atrogin-1 is increased in atrophied muscles[@ref2]. Furthermore, the activation of the ubiquitin-proteasome pathway has been correlated with an increased expression of atrogin-1 and ubiquitinated proteins[@ref23]. Therefore, the increased expression of atrogin-1 and the ubiquitinated proteins are an indicator of the activated ubiquitin-proteasome pathway. On the other hand, it has been suggested that sepsis can induce the up-regulation of inflammatory cytokines[@ref24]. In inflammatory cytokine-induced atrophied muscles, the rates of protein degradation increase through the activation of the ubiquitin-proteasome pathway[@ref2]. The deactivation of the Akt signaling pathway is involved in the activation of the ubiquitin-proteasome pathway via the dephosphorylation of the forkhead box O (FoxO) class of transcription factors. These factors have been identified as key regulators of the ubiquitin-proteasome pathway, which are located downstream of the Akt signaling pathway. In addition, the Akt signaling pathway can suppress the activation of the ubiquitin-proteasome pathway via FoxO phosphorylation[@ref25]. A previous study indicated that the Akt signaling pathway was suppressed by inflammatory cytokines such as TNF-α[@ref25]. In addition, it has been suggested that up-regulation of myostatin expression was caused by inflammatory diseases such as sepsis and deactivated Akt signaling pathway[@ref26]. These findings suggest that increased levels of inflammatory cytokines may be induced by the activation of the ubiquitin-proteasome pathway through the suppression of the Akt signaling pathway, which is consistent with the results of the present study.

In a previous study, it was reported that electrical stimulation attenuated disuse-induced muscle atrophy in the tibialis anterior muscle[@ref8]. In addition, the conductivity of the kilohertz frequency may contribute to its effectiveness in preventing atrophy in a vast area of muscle compared to the effects of low frequency electrical stimulation[@ref13]. Furthermore, electrical stimulation using kilohertz frequency was effective for muscle atrophy of muscle fibers located deep layer of skeletal muscle[@ref13]. Whereas, our and other previous studies have suggested that low frequency electrical stimulation was not effective for deep muscle fibers[@ref13],[@ref27]. In the present study, the results of muscle fiber cross-sectional area located superficial and deep muscle fibers suggested that electrical stimulation using kilohertz frequency was effective for muscle atrophy in both the superficial and the deep muscle fibers. Therefore, electrical stimulation using kilohertz frequency could induce a contraction of a large area of muscle fibers in the present study.

We found that electrical stimulation using kilohertz frequency attenuated the expression of atrogin-1 and ubiquitinated proteins in the tibialis anterior muscle, which resulted in an inhibition of the atrophy-induced morphological reductions. It is possible that the exercise-induced muscle contractions could activate the Akt signaling pathway[@ref28],[@ref29]. In addition, it has been suggested that up-regulation of myostatin expression induced by systemic inflammatory diseases such as heart failure, cancer, and sepsis was attenuated by exercise-induced muscle contractions[@ref30],[@ref31]. Electrical stimulation can induce muscle contractions directly. In addition, these effects depend on the intensity of the muscle contraction, which in turn depends on muscle fiber recruitment[@ref32]. These findings suggest that the contraction of a vast area of muscle induced by kilohertz frequency electrical stimulation could lead to the effective suppression of the deactivated Akt signaling pathway. Therefore, kilohertz frequency electrical stimulation induced a contraction of a large area of muscle fibers; the appropriate amount of muscle contraction could inhibit the activation of the ubiquitin-proteasome pathway through a suppression of a deactivated intracellular signaling pathway, such as the Akt signaling pathway.

Our results demonstrate that electrical stimulation failed to attenuate the increase in plasma and muscle TNF-α levels. It has been suggested that LPS-induced TNF-α, which was induced muscle atrophy, is produced in classic immune tissues, such as the liver, spleen, and lung[@ref33]. The produced TNF-α can deactivate intracellular signaling pathways, such as Akt signaling pathway, in skeletal muscles[@ref21]. In addition, although aerobic exercise training has anti-inflammatory effects, resistance training can have an anti-catabolic effect for systemic inflammation[@ref34],[@ref35]. The electrical stimulation could induce resistance training and muscle contractions to a limited number of muscles located under the electrodes. In addition, it has been suggested that high intensity exercise training can induce increasing systemic inflammation[@ref36]. The attenuated effect of systemic inflammatory cytokines using electrical stimulation may be limited in the present study. However, in sepsis, it could attenuate the deactivation of intracellular signaling pathways in skeletal muscles undergoing muscle contractions without an increase in systemic inflammatory cytokines. Therefore, it may be essential to induce muscle contractions for prevention of sepsis-induced muscle atrophy.

The results of the present study demonstrate that kilohertz frequency electrical stimulation was effective for the prevention of sepsis-induced muscle atrophy. Several studies have suggested that the sepsis-induced muscle atrophy is closely linked to the decline of activity of daily living (ADL)[@ref37]-[@ref39]. In addition, the severity of sepsis is related with the length of an intensive care unit (ICU) stay and muscle atrophy progression[@ref40]. Furthermore, it is important to inhibit sepsis-induced muscle atrophy in order to shorten the length of ICU stays and improve muscle atrophy after severe sepsis[@ref41]. Therefore, the results in the present study suggest that kilohertz frequency electrical stimulation could prevent sepsis-induced muscle atrophy, which would reduce ICU stay length and the recovery from ADL decline.

In conclusion, the kilohertz frequency electrical stimulation inhibited sepsis-induced muscle atrophy. Additionally, the electrical stimulation inhibited the activation of the ubiquitin-proteasome pathway through the suppression of the deactivated Akt signaling pathway in calf muscles. These results suggest that kilohertz frequency electrical stimulation has the potential to become an effective therapeutic intervention for the prevention of sepsis-induced muscle atrophy.
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